• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Consumer Cyclical·ALRPD.PA
Share

Rapid Nutrition PLC Stocks

€ 3.37Last Updated 24.08.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

€ 1.91M

€ 3.37
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rapid Nutrition PLC is a natural healthcare enterprise that researches, develops, and manufactures a diverse portfolio of science-backed health and wellness products. Its market presence extends across the United Kingdom, Australia, Asia, the United States, and other international regions. The company offers a range of organic and natural, scientifically formulated health food supplements, primarily distributed under the SystemLS and Leisa's Secret trademarks. Furthermore, it produces oral antiviral therapeutic solutions, marketed as Azurene, aimed at combating influenza and the common cold. The company was established in 2001 and is headquartered in London, UK.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is 'cheap' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.08.2026 12:45

The SEC will investigate Wall Street's largest banks over loans to the "AI Nostradamus" fund

25.08.2026 11:53

The SpaceX Acquisition and Allegations of Insider Trading: How Trump's Investments Work

25.08.2026 10:51

Bets on a weakening dollar pushed Bitcoin back above $80,000 for the first time since spring

25.08.2026 10:34

Morning Highlights: The Dollar Strengthened, Bitcoin Surpassed $80,000, and Meta Is Developing AI Products

25.08.2026 03:44

Trump has threatened Canada with new 50% tariffs. Who stands to lose?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026